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Penile Mondor's disease can be effectively treated with the use
of an acetyl salicylic acid and pentoxifylline combination
Mürsel DAVARCI, Eşref Oğuz GÜVEN, Ahmet GÖKÇE, Fatih Rüştü YALÇINKAYA, Ahmet Namık KİPER,
Mevlana Derya BALBAY
Aim: Since penile Mondor's disease is a rare condition, different treatment choices are used. Herein we recommend a new
treatment strategy with acetylsalicylic acid and pentoxifylline, which was tested in 14 patients with penile Mondor’s
disease.
Materials and methods: Fourteen patients with the clinical presentation of penile Mondor's disease were included.
Patients were given acetylsalicylic acid (ASA) 500 mg qid and pentoxifylline 600 mg bid for 14 days. Physical examinations
were performed in all patients. In addition, ultrasonic examinations were done before the treatment and on days 7 and
14 of treatment to evaluate dorsal vein thrombosis.
Results: Physical examinations revealed lesions parallel to the coronal sulcus in 9 patients and in the dorsal aspect of the
proximal penis in 5 patients. All patients had painful induration of the penis. On day 7, hyperechoic structures were still
observed in 8 patients and no thrombus was seen in 6 patients. Ultrasonographic measurements were repeated 14 days
after treatment and a hyperechoic structure was observed in 4 patients. No side effects were encountered during the
follow-up period.
Conclusion: We think that the ASA and pentoxifylline protocol, which is also used for the treatment of thrombotic
events in other parts of the body, helps to resolve penile Mondor’s disease in a shorter time compared to previous
treatment protocols. Further randomized controlled studies are needed for a definitive decision.
Key words: Mondor's disease, thrombophlebitis, dorsal vein thrombosis, penis

Penil Mondor hastalığı asetilsalisilik asit ve pentoksifilin kombinasyonu kullanarak
etkili olarak tedavi edilebilir
Amaç: Penil Mondor hastalığı nadir bir durum olduğundan, bugüne değin farklı tedavi yöntemleri kullanılmıştır. Bu
nedenle biz de bu çalışmamızda Penil Mondor hastalığı olan 14 hastada asetil salisilik asit (ASA) ve pentoksifilin ile yeni
bir tedavi stratejisi önerdik.
Yöntem ve gereç: Bu çalışmaya penil Mondor hastalığı olan 14 hasta dahil edildi. Hastalara 14 gün boyunca ağız yoluyla
ASA günde dört kez 500 mg ve pentoksifilin günde 2 kez 600 mg verildi. Fizik muayeneleri yapıldı. Tüm hastalara tedaviye
başlamadan önce ve tedavinin 7. ve 14. günlerinde dorsal vendeki trombozisi değerlendirmek için ultrason yapıldı.
Bulgular: Fizik muayenede 9 hastada koronal sulkusa paralel ve 5 hastada proksimal penisin dorsal yüzünde lezyonlar
gözlendi. Tüm hastalarda peniste ağrılı endurasyon vardı. 7. Gün ultrasonlarında 8 hastada penil dorsal veninde trombüsle
uyumlu hiperekoik yapılar gözlendi. 6 hastada ise trombus izlenmedi. 14. gün yapılan ultrasonlarında ise, 4 hastada penil
dorsal vende trombüsle uyumlu hiperekoik yapılar tekrar gözlendi. Takip süresince hiçbir yan etkiyle karşılaşılmadı.
Sonuç: Penil Mondor Hastalığının, vücudun diğer bölgelerinde gelişen trombotik olayların tedavisinde de kullanılan
ASA ve pentoksifilin protokoluyla, önceki tedavi protokollerine oranla daha kısa sürede tedavi edilebileceğine inanıyoruz.
Ancak kesin yargıya varmak için randomize kontrollü çalışmalara ihtiyaç vardır.
Anahtar sözcükler: Mondor hastalığı, tromboflebit, dorsal ven trombozu, penis
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Introduction
Superficial vein thrombosis was initially described
by Mondor in 1939 in the subcutaneous veins of the
anterolateral thoraco-abdominal wall (1). Penile
Mondor’s disease was first described in the 1950s by
Braun-Falco and then Helm and Hodge. Its incidence
has recently been estimated as 1.39% (2). The underlying
pathology is not completely understood yet, but
stretching and torsion of penile veins due to prolonged
and vigorous sexual intercourse is the most frequently
blamed etiology. Previously, it has been treated with
antibiotics, antiinflammatory drugs and local dressings
containing heparin in most cases (3-5). Since the
thrombi triggered mainly by trauma in the superficial
vein of the penis are blamed for the symptoms in penile
Mondor’s disease, we decided to treat them with
acetylsalicylic acid (ASA) and pentoxifylline for the first
time. To the best of our knowledge, this is the first study
that presents a series of penile Mondor’s patients treated
with ASA and pentoxifylline in the English literature.
Materials and methods
Between January 2004 and December 2009, we
treated 14 patients with the clinical presentation of a
superficial penile vein thrombosis (SPVT) after
obtaining their informed consent. All patients were
admitted in the acute period. The interval between the
onset of the patients’ symptoms and their admittance to
the clinic was a mean of 2.4 days (1-5 days). Additionally
no fever increases were reported in the patients’ histories.
All patients had instantaneous and painful subcutaneous
induration of the dorsal penile surface. For all patients,
after a detailed anamnesis, ultrasonography (Doppler
ultrasonography of penile vessels) and routine laboratory
analysis (blood count, electrolytes, and coagulation tests)
were performed. Primary therapy was medical, with oral
application of ASA 500 mg qid and pentoxifylline 600
mg bid for 14 days. Follow-up examinations were done
on days 7 and 15 of the treatment. Clinical improvement
was judged by improvement in the pain and induration.
All of the patients were reassured of the benign
nature of their conditions and were instructed to refrain
from sexual activity until the problem resolved.
Results
The median age of the patients with the combined
treatment was 40.5 ± 10.5 and the time to treatment
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response was 12.6 ± 1.5 (10-15) days. The standard
laboratory tests before treatment were all normal in 14
patients. In the anamnesis thrombosis occurred after
exaggerated sexual intercourse in 4 patients, in the
remaining group 5 patients reported that they had had at
least 10 days of sexual abstinence. The 5 remaining
patients had no specific anamnesis before the
development of their painful superficial thrombosis of
the penis. Physical examinations revealed in 9 patients
that the lesions were parallel to the coronal sulcus (giving
the appearance of a double coronal sulcus) and 5 other
patients had lesions in the dorsal aspect of the proximal
penis. The length of the thrombotic vein was between
0.5 and 3 cm. The ultrasonographic findings were similar
in all patients. A hyperechoic structure was found in the
superficial dorsal vein. No venous flow signals were
detected in this area of the blood vessel in Doppler
ultrasonography. The diameter of the obstructed veins
was 3.24 ± 0.07 mm; range 2.8-3.8. Seven days after their
first visit, 10 patients reported a decrease in the intensity
of their pain and 4 patients continued to report palpable
swellings. After a week on ASA and pentoxifylline
treatment ultrasonographic measurements were
repeated. The diameters of the involved veins did not
change: 3.19 ± 0.07 mm, range 2.8-3.6; hyperechoic
structures were still observed in 8 patients; and no
thrombus was seen in 6 patients. Venous diameters were
measured 14 days after treatment and found to be 2.97 ±
0.06 mm, range 2.8-3.6; and hyperechoic structure was
observed in 4 patients. Those patients with persisting
thrombi on ultrasound at 14 days were lost to follow up.
No side effects were encountered during the follow-up
period (Tables 1 and 2, Figure).
Discussion
Since its first description by Braun-Falco in the
1950s, several treatment strategies were used to treat
penile Mondor’s disease. Previously, it was treated with
antibiotics, antiinflammatory drugs, and local dressings
containing heparin in most cases (3-5). The penile
venous system can be influenced by inflammatory
processes under certain conditions, such as sexual
trauma in the dorsal region and thrombophlebitis of the
ventral portion (5). Thrombosis of the dorsal vein of
the penis is an unusual condition that tends to influence
males between 21 and 70 years of age (6,7). In our study,
the average age was 40 years, with the youngest and
oldest patients being 25 and 65, respectively.
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Percent
(%)

Exaggerated sexual intercourse

4

28

At least 10 days of sexual abstinence

5

36

No specific anamnesis

5

36

TOTAL

14
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Figure. Decrease in the visible thrombosis in superficial penile
veins on ultrasound.

Published data on superficial penile vein thrombosis
are unusual and mostly reported as single-case studies,
except a few with 5 patients and more (3,4,6,8). The
largest study has been performed by Al-Mwalad with
25 patients (8). Our study is the second largest study in
literature, with 14 patients.
Mondor’s disease is a benign and generally a selflimited procedure. Patients complain of a cord-like
induration, which is often painful, in the dorsal facet of
the penis, and this pain can be continuous or episodic.
All of the patients in our study had painful sexual
intercourse.
The etiology of this condition is commonly
unfamiliar, but several causative factors have been
reported, e.g., idiopathic (9), penile trauma,

Table 2. Evolution of Doppler penile ultrasound findings on
treatment.
Mean ± SEM
Day 0

Thrombosis (+) (n = 14, 100%)
Thrombosis (-)

VEINS’ DIAMETERS

Location of Thrombus on
Physical Examination

Anamnesis

Table 1. Findings in patients’ histories and physical examinations.

TOTAL
DAY 7

__

(n = 14, 100%)

3.24 ± 0.07

Thrombosis (+)

(n = 8, 53%)

3.33 ± 0.09

Thrombosis (-)

(n = 6, 47%)

3.00 ± 0.06

(n = 14, 100%)

3.19 ± 0.07

(n = 4, 29%)

3.18 ± 0.14

Thrombosis (-) (n = 10, 71%)

2.9 ± 0.05

TOTAL

2.97 ± 0.06

TOTAL
DAY 14

(n = 0, 0%)

3.24±0.07

Thrombosis (+)

(n = 14, 100%)

immoderate sexual activity, extended sexual avoidance,
infection, pelvic tumors, and constrictive elements used
during certain sexual practices; of these, the trauma
caused by sexual intercourse appears to be the principal
etiologic factor (10,11). In our study thrombosis
occurred after exaggerated sexual intercourse in 4
patients; in the remaining group 5 patients reported
that they had had at least 10 days of sexual abstinence.
The 5 remaining patients had no specific anamnesis
before the development of their painful superficial
thrombosis of the penis.
Ultrasound and Doppler ultrasound investigations
were adequate to evaluate the extent of the thrombosis
(6). According to the results of our study and previous
published studies, extra invasive diagnostic protocols
do not provide more information on the management
of the thrombosis (3-7). However, a recent published
article focused on the usefulness of MR-angiography to
deepen the diagnostic pathway whenever a complex
pathogenesis was suspected (12).
A sequence of treatment choices is available, in
accordance with the clinical stage of the disorder. In
principle the best approach seems to be conservative
management, assuring the patient about the benign
nature of their condition and recommending sexual
abstinence until full healing has occurred. Treatments
include antiinflammatory drugs, antibiotics, and local
heparin-containing creams (8,11,13). Pentoxifylline
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(Trental, Aventis Pharmaceuticals Inc. Kansas City,
MO, USA), a trisubstituted xanthine derivative, is a
hemorheologic agent that has been in use since the
1970s. The primary indication for its use was for the
treatment of intermittent claudication due to arterial
occlusive disease in the lower extremities.
Pentoxifylline has also been used to treat other
diseases, including venous stasis leg ulcers, sepsis, and
hepatic fibrosis (14-16). The mechanism of the effect
of pentoxifylline is poorly understood. Pentoxifylline
reduces blood viscosity by increasing erythrocyte
flexibility, reduces platelet aggregation, increases
leukocyte migration, and reduces plasma viscosity
(17). Since the thrombi triggered mainly by trauma in
the superficial vein of the penis are blamed for the
symptoms in penile Mondor’s disease, it would be
reasonable to use an agent that has multiple effects on
blood viscosity. Therefore, we administered
pentoxifylline and ASA for the first time in penile
Mondor’s disease in our study. The acute
presentations in all cases were treated very effectively
with ASA and pentoxifylline. Before the treatment,

thrombi were detected in 100% of the patients,
ultrasonographically. The detection rates of thrombi
were 53% and 29% after 7 and 14 days of treatment,
respectively. To our knowledge this is the first
presentation of a series of Mondor’s patients treated
with ASA and pentoxifylline in the English literature.
In advanced stages, antiinflammatory drugs and local
heparin-containing creams can be prescribed. Local
anesthetic infiltration around the affected venous
segment can be useful for treating the pain, though it
proves ineffective in cases of infection;
antiinflammatory drugs and antibiotics are indicated
in such situations. In tenacious cases surgery may be
necessary, with thrombectomy or resection of the
superficial dorsal vein (11).
In conclusion, penile Mondor’s disease can be
effectively treated with ASA 500 mg qid and
pentoxifylline 600 mg bid for 14 days, a treatment
method also used for thrombotic events in other parts
of the body. We think that this treatment protocol helps
to resolve thrombotic penile disease conservatively and
in a shorter time than previous treatment protocols.
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